文献速递甲状腺疾病

50例COVID-19患者甲状腺功能分析:一项回顾性研究

Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study.
PubMed 文献 · Thyroid · 2020-07-10

该回顾性研究纳入50例无甲状腺疾病史的实验室确诊COVID-19患者,分析其感染期及恢复后的甲状腺功能,并与健康对照及非COVID-19肺炎患者比较。结果显示COVID-19患者TSH和TT3水平显著低于对照组,且降低程度与疾病严重程度相关;恢复后甲状腺功能指标与对照组无显著差异。

要点

  • 56%(28/50)的COVID-19患者TSH低于正常范围。
  • COVID-19患者TSH和TT3水平显著低于健康对照及非COVID-19肺炎患者。
  • COVID-19病情越重,TSH和TT3水平越低(p < 0.001),恢复后与对照组无显著差异。

核心结论

  • 血清TSH和TT3水平的变化可能是COVID-19病程的重要表现。

研究设计与样本

  • 回顾性研究纳入50例无甲状腺疾病史的实验室确诊COVID-19患者,于2020年1月至3月在浙江大学医学院附属第一医院就诊,并设健康对照及非COVID-19肺炎对照。

主要发现

  • 56%(28/50)的COVID-19患者TSH低于正常范围。
  • COVID-19患者TSH和TT3水平显著低于健康对照组和非COVID-19肺炎患者。
  • COVID-19病情越重,TSH和TT3水平越低,差异有统计学意义(p < 0.001),且降低程度与疾病严重程度正相关。
  • COVID-19患者TT4水平与对照组无显著差异。
  • 所有患者均未接受甲状腺激素替代治疗;恢复后TSH、TT3、TT4、fT3、fT4水平与对照组无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Since the outbreak of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019, it has affected >200 countries, areas, or territories in 6 continents. At present, whether COVID-19 has an effect on thyroid function is unclear. The aim of this study was to evaluate thyroid function in patients with COVID-19. Methods: Clinical manifestations, laboratory results, and chest computed tomography scans were retrospectively reviewed for 50 patients with laboratory-confirmed COVID-19 without a history of thyroid disease who underwent thyroid function testing during their course of COVID-19 infection and after recovery. They were admitted to the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China, between January and March 2020. Healthy participants who underwent routine physical checkups and non-COVID-19 pneumonia patients with a similar degree of severity during the same period were included in the study as the control group. Thyroid hormone and thyrotropin (TSH) levels were analyzed and compared between the COVID-19 and control groups. Results: TSH lower than the normal range was present in 56% (28/50) of the patients with COVID-19. The levels of TSH and serum total triiodothyronine (TT3) of the patients with COVID-19 were significantly lower than those of the healthy control group and non-COVID-19 pneumonia patients. The more severe the COVID-19, the lower the TSH and TT3 levels were, with statistical significance (p < 0.001). The degree of the decreases in TSH and TT3 levels was positively correlated with the severity of the disease. The total thyroxine (TT4) level of the patients with COVID-19 was not significantly different from the control group. All the patients did not receive thyroid hormone replacement therapy. After recovery, no significant differences in TSH, TT3, TT4, free triiodothyronine (fT3), and free thyroxine (fT4) levels were found between the COVID-19 and control groups. Conclusions: The changes in serum TSH and TT3 levels may be important manifestations of the courses of COVID-19.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Chen M, Zhou W, Xu W, et al. Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective Study. Thyroid. 2020. PMID: 32600165. doi:10.1089/thy.2020.0363

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。